Delivery Order SPE2DR25D3501-SPE2DR26FM0KH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,553.83 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 10, 2025, with completion scheduled for December 11, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is performed at the contractor's headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,358.85 for Trulicity 1.5 mg/0.5 mL pens on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $7,142.61 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.46 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens (0.5 ml quantity) on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.73 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $5,964.68 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $4,035.46. This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,369.06 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM0KHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,218.34 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 11, 2025, with a completion date of December 12, 2025. This firm fixed-price delivery order, which is unclassified and carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution hub for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999,999,999 indefinite delivery contract with DLA that runs through December 2026, positioning the company as a critical vendor for federal military and veteran healthcare systems. This delivery order for Trulicity, a diabetes medication widely used across the Defense Health Agency and other government healthcare systems, exemplifies the company's role in supplying brand-name pharmaceuticals to support military medical programs. The contract reflects DLA's continued reliance on AmerisourceBergen's comprehensive pharmaceutical supply chain capabilities to fulfill ongoing federal medical requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/10/25 |